CL2022002215A1 - Polipéptidos y sus usos - Google Patents
Polipéptidos y sus usosInfo
- Publication number
- CL2022002215A1 CL2022002215A1 CL2022002215A CL2022002215A CL2022002215A1 CL 2022002215 A1 CL2022002215 A1 CL 2022002215A1 CL 2022002215 A CL2022002215 A CL 2022002215A CL 2022002215 A CL2022002215 A CL 2022002215A CL 2022002215 A1 CL2022002215 A1 CL 2022002215A1
- Authority
- CL
- Chile
- Prior art keywords
- polypeptides
- nanoparticles
- designing
- methods
- fusion proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/20—Protein or domain folding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/50—Mutagenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2025002147A CL2025002147A1 (es) | 2020-02-14 | 2025-07-21 | Polipéptidos y sus usos |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062977036P | 2020-02-14 | 2020-02-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2022002215A1 true CL2022002215A1 (es) | 2023-05-05 |
Family
ID=77292738
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2022002215A CL2022002215A1 (es) | 2020-02-14 | 2022-08-12 | Polipéptidos y sus usos |
| CL2025002147A CL2025002147A1 (es) | 2020-02-14 | 2025-07-21 | Polipéptidos y sus usos |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2025002147A CL2025002147A1 (es) | 2020-02-14 | 2025-07-21 | Polipéptidos y sus usos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230075095A1 (https=) |
| EP (1) | EP4103586A4 (https=) |
| JP (1) | JP2023513592A (https=) |
| KR (1) | KR20220142471A (https=) |
| AU (1) | AU2021220958A1 (https=) |
| BR (1) | BR112022016197A2 (https=) |
| CL (2) | CL2022002215A1 (https=) |
| CO (1) | CO2022011395A2 (https=) |
| PE (1) | PE20230486A1 (https=) |
| WO (1) | WO2021163481A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114933657B (zh) * | 2021-08-25 | 2024-02-02 | 上海交通大学医学院 | 神经生长因子突变体重组蛋白及其应用 |
| KR102527221B1 (ko) * | 2021-10-15 | 2023-05-02 | 에스케이바이오사이언스 주식회사 | 단백질의 정제방법 |
| WO2023196871A2 (en) * | 2022-04-07 | 2023-10-12 | University Of Washington | Secretion-optimized de novo designed protein nanoparticles for eukaryotic expression and genetic delivery |
| EP4704892A2 (en) | 2023-05-01 | 2026-03-11 | University of Washington | Pre-fusion-stabilized cmv gb protein nanostructures |
| WO2025059498A2 (en) * | 2023-09-15 | 2025-03-20 | Icosavax, Inc. | Viral proteins and nanostructures and uses thereof |
| WO2025144636A1 (en) * | 2023-12-26 | 2025-07-03 | The Scripps Research Institute | ENGINEERED hMPV F PROTEIN IMMUNOGENS AND RELATED VACCINES |
| WO2025207938A1 (en) * | 2024-03-29 | 2025-10-02 | University Of Washington | Nucleic acid vaccines against coccidioidomycosis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005123763A1 (en) * | 2004-06-16 | 2005-12-29 | Dsm Ip Assets B.V. | Production of polypeptides by improved secretion |
| US9630994B2 (en) * | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| WO2016138525A1 (en) * | 2015-02-27 | 2016-09-01 | University Of Washington | Polypeptide assemblies and methods for the production thereof |
| CN107002074B (zh) * | 2015-06-10 | 2021-08-10 | 公立大学法人富山县立大学 | 活性型突变酶的制造方法及活性型突变酶、以及可溶性化突变蛋白的制造方法 |
| JP6957039B2 (ja) * | 2016-09-06 | 2021-11-02 | 学校法人慶應義塾 | 融合タンパク質、構造体、捕集剤、捕集する方法、ｄｎａ、及びベクター |
| US11866699B2 (en) * | 2017-02-10 | 2024-01-09 | University Of Washington | Genome editing reagents and their use |
| HUE073526T2 (hu) * | 2017-04-04 | 2026-01-28 | Univ Washington | Önmagát összeállító fehérje nanostruktúrák, amelyek paramyxovírus és/vagy pneumovírus F fehérjéket jelenítenek meg és azok használata |
| WO2019169120A1 (en) * | 2018-02-28 | 2019-09-06 | University Of Washington | Self-asssembling nanostructure vaccines |
| WO2019241483A1 (en) * | 2018-06-13 | 2019-12-19 | The Scripps Research Institute | Nanoparticle vaccines with novel structural components |
| FR3083804B1 (fr) * | 2018-07-13 | 2022-08-12 | Institut Nat Des Sciences Appliquees De Toulouse | Micro-organismes et procede pour la production d'acide glycolique a partir de pentoses et d'hexoses |
-
2021
- 2021-02-12 PE PE2022001740A patent/PE20230486A1/es unknown
- 2021-02-12 AU AU2021220958A patent/AU2021220958A1/en active Pending
- 2021-02-12 EP EP21753413.0A patent/EP4103586A4/en active Pending
- 2021-02-12 BR BR112022016197A patent/BR112022016197A2/pt unknown
- 2021-02-12 KR KR1020227031325A patent/KR20220142471A/ko active Pending
- 2021-02-12 US US17/760,180 patent/US20230075095A1/en active Pending
- 2021-02-12 JP JP2022549070A patent/JP2023513592A/ja active Pending
- 2021-02-12 WO PCT/US2021/017856 patent/WO2021163481A1/en not_active Ceased
-
2022
- 2022-08-12 CO CONC2022/0011395A patent/CO2022011395A2/es unknown
- 2022-08-12 CL CL2022002215A patent/CL2022002215A1/es unknown
-
2025
- 2025-07-21 CL CL2025002147A patent/CL2025002147A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112022016197A2 (pt) | 2022-10-25 |
| AU2021220958A1 (en) | 2022-09-01 |
| CL2025002147A1 (es) | 2026-03-06 |
| US20230075095A1 (en) | 2023-03-09 |
| JP2023513592A (ja) | 2023-03-31 |
| CO2022011395A2 (es) | 2023-01-16 |
| WO2021163481A1 (en) | 2021-08-19 |
| EP4103586A1 (en) | 2022-12-21 |
| KR20220142471A (ko) | 2022-10-21 |
| EP4103586A4 (en) | 2024-05-15 |
| PE20230486A1 (es) | 2023-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022011395A2 (es) | Polipéptidos y sus usos | |
| CO2021017741A2 (es) | Proteínas de fusión flt3l-fc y métodos de uso | |
| CL2024003234A1 (es) | Polipéptidos modificados y usos de los mismos. | |
| MX2018003144A (es) | Dominios de superfamilia de inmunoglobulina de variante ajustable y terapia con células genéticamente modificadas. | |
| MX2024000006A (es) | Proteinas de fusion inmunomoduladoras y sus usos. | |
| CO2019000395A2 (es) | Genes de mini–distrofina optimizados y casetes de expresión y su uso | |
| MX2023005612A (es) | Celulas modificadas que expresan antigeno de membrana especifico de prostata (psma) o una forma modificada del mismo y metodos relacionados. | |
| CL2021001779A1 (es) | Polipéptidos que comprenden polipéptidos con il-2 modificada y usos de los mismos | |
| PE20151774A1 (es) | Construcciones de proteinas mitocondriales y sus usos | |
| SV2016005264A (es) | Proteínas de fusión tatk-cdkl5, composiciones, formulaciones y uso de estas | |
| UY35416A (es) | Anticuerpos humanos de la proteína f del virus respiratorio sincicial y métodos de uso de estos. | |
| UY37341A (es) | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada | |
| UY36370A (es) | Polipéptidos fgf-21 modificados y sus usos | |
| AR106144A1 (es) | Un conjugado de proteína que comprende polipéptidos fisiológicos y una región fc inmunoglobulina | |
| PE20211660A1 (es) | Neoantigenos prostaticos y sus usos | |
| EA201791918A1 (ru) | Модификация белков клеток-хозяев | |
| BR112017019072A2 (pt) | membrana de troca de íons, sistemas eletroquímicos, e métodos | |
| AR095268A1 (es) | ANTICUERPOS HUMANOS QUE SE UNEN AL FACTOR a DE LA NECROSIS (TNF-a) HUMANO Y MÉTODOS PARA PREPARARLOS | |
| MX377780B (es) | Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes. | |
| DOP2015000211A (es) | Anticuerpos anti-cd52 | |
| CO2023010689A2 (es) | Anticuerpos y usos de estos | |
| UY37975A (es) | Nuevos antigenos de proteinas de la envoltura del virus de la inmunodeficiencia humana (vih) expresados en celulas de mamiferos | |
| MX2018007298A (es) | Variantes con mejores propiedades de polipéptidos de fusión relacionados con omega-hidroxilasa. | |
| CL2016002239A1 (es) | Medios de anclaje con cable para una junta horizontal, y procedimiento de anclaje con cable para una junta horizontal. | |
| ECSP22019177A (es) | Proteínas de fusión nkg2d y sus usos |